Matilda Berkell

473 citations
23 papers · 349 · h-index 8

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • Clostridium difficile and Clostridium perfringens research
    • COVID-19 Clinical Research Studies
    • Long-Term Effects of COVID-19

Papers in

    • SARS-CoV-2 and COVID-19 Research 11
    • COVID-19 Clinical Research Studies 2
    • Clostridium difficile and Clostridium perfringens research 2
    • Long-Term Effects of COVID-19 2

Matilda Berkell

17 papers receiving 340 citations

Peers

Matilda Berkell
Comparison fields: 5 of 60
  • Infectious Diseases 157
  • Neurology 60
  • Applied Microbiology and Biotechnology 4
  • Immunology 28
  • Molecular Biology 66
Replace Jill M. C. Hakim with:
Jill M. C. Hakim United States
Bernd Kochanowski Germany
Tsuneo Maegawa Japan
Brian D. Carey United States
Marisol Zuniga United States
Jennifer M. Schneider United States
Yale A. Santos United States
Awadalkareem Adam United States
Willem van Snippenberg Belgium
Mina Mobini Kesheh Iran
Matilda Berkell relative to Jill M. C. Hakim United States Jill M. C. Hakim's profile →
Citations per field
00.5×1.5×
Jill M. C. Hakim · 1×
Citations per year

Countries citing papers authored by Matilda Berkell

Since Specialization
Citations

This map shows the geographic impact of Matilda Berkell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matilda Berkell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matilda Berkell more than expected).

Fields of papers citing papers by Matilda Berkell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matilda Berkell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matilda Berkell. The network helps show where Matilda Berkell may publish in the future.

Co-authors

The 25 scholars most cited alongside Matilda Berkell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matilda Berkell Line = papers co-authored together Matilda Berkell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1 202374
2 202165
3 202363
4 202335
5 202130
6 202220
7 202215
8 20238
9 20227
10 20247
11 20246
12 20215
13 20214
14 20223
15 20223
16 20222
17 20242
18 20250
19 20250
20 20250

About Matilda Berkell

Matilda Berkell is a scholar working on Infectious Diseases, Neurology, Genetics, Applied Microbiology and Biotechnology and Endocrinology, having authored 23 papers that have together received 349 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (2 papers), Long-Term Effects of COVID-19 (2 papers), Genetic Associations and Epidemiology (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Bacterial biofilms and quorum sensing (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Infectious Diseases (157 citations), Neurology (60 citations), Applied Microbiology and Biotechnology (4 citations), Immunology (28 citations) and Molecular Biology (66 citations). Matilda Berkell has collaborated with scholars based in Belgium, Italy and United States. Frequent co-authors include Samir Kumar‐Singh, Surbhi Malhotra‐Kumar, Basil Britto Xavier, Herman Goossens, An Hotterbeekx, Elisa Danese, E. Suzanne Cohen, Alessia Savoldi, Qiang Lin and Jean-Pierre Hernálsteens. Their work appears in journals such as Eurosurveillance, Nature Communications, Frontiers in Immunology, Clinical Microbiology and Infection and mSystems.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact